![Myles Greenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Myles Greenberg
Directeur Général chez
InCarda Therapeutics, Inc.
Profil
Myles D.
Greenberg is currently Chief Executive Officer at InCarda Therapeutics, Inc. since 2024.
He is a Director at Urgent Care Centers of New England, Inc. He is a Partner at CHL Healthcare Partners LLC since 2013 and a Venture Partner at Healthinvest Equity Partners.
Formerly, Dr. Greenberg was President, Chief Executive Officer & Director at Alucent Biomedical Inc. from 2017 to 2024.
He served as Chairman at Cantex Pharmaceuticals, Inc. and held Director positions at Oriel Therapeutics, Inc., Angiomics, Inc., Millennium Pharmacy Systems, Inc., NuVasive LLC, Dynogen Pharmaceuticals, Inc., Vertos Medical, Inc., Ivrea Pharmaceuticals, Inc., Oculir, Inc., DICOM Grid, Inc., FlowCardia, Inc., and Mevion Medical Systems, Inc. as an Independent Director.
He was Assistant Clinical Director-Emergency Department at Beth Israel Deaconess Medical Center, Inc. and Assistant Clinical Director-Emergency Medicine at Harvard Medical School.
He was Senior Principal at Pappas Capital LLC from 2000 to 2003 and Assistant Professor at UNC School of Medicine.
Education includes an MBA from Harvard Business School in 2000, a doctorate from Yale School of Medicine in 1993, and an undergraduate degree from the School of Engineering & Applied Science in 1989.
Postes actifs de Myles Greenberg
| Sociétés | Poste | Début |
|---|---|---|
CHL Healthcare Partners LLC
 CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements. | Private Equity Investor | 01/01/2004 |
Urgent Care Centers of New England, Inc.
 Urgent Care Centers of New England, Inc. Medical/Nursing ServicesHealth Services Provides urgent care services | Directeur/Membre du Conseil | - |
Healthinvest Equity Partners
 Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of healthcare service sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders | Directeur Général | 10/12/2024 |
Anciens postes connus de Myles Greenberg
| Sociétés | Poste | Fin |
|---|---|---|
Alucent Biomedical Inc.
 Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical company | Directeur Général | 02/11/2024 |
Oculir, Inc.
 Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Directeur/Membre du Conseil | 23/10/2008 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Corporate Officer/Principal | 31/12/2003 |
Millennium Pharmacy Systems, Inc.
 Millennium Pharmacy Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical management services | Directeur/Membre du Conseil | - |
| NUVASIVE, INC. | Directeur/Membre du Conseil | - |
Formation de Myles Greenberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Oriel Therapeutics, Inc.
 Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Health Technology |
Angiomics, Inc. | |
Millennium Pharmacy Systems, Inc.
Millennium Pharmacy Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical management services | Commercial Services |
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Mevion Medical Systems, Inc.
 Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops proton therapy systems to treat cancer | Health Technology |
Vertos Medical, Inc.
 Vertos Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets invasive devices for treatment of lumbar spinal stenosis | Health Technology |
Ivrea Pharmaceuticals, Inc.
 Ivrea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for dermatologic conditions | Health Technology |
Oculir, Inc.
Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
DICOM Grid, Inc.
 DICOM Grid, Inc. Packaged SoftwareTechnology Services Develops medical data and image management SaaS platform | Technology Services |
Cantex Pharmaceuticals, Inc.
 Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops heparin to ameliorate cardiac ischemia-reperfusion injuries | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
CHL Healthcare Partners LLC
CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements. | Finance |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures endovascular devices | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders | Commercial Services |
Urgent Care Centers of New England, Inc.
Urgent Care Centers of New England, Inc. Medical/Nursing ServicesHealth Services Provides urgent care services | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
School of Engineering & Applied Science
 School of Engineering & Applied Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of healthcare service sector. It provides financing for early stage capital requirements. | Finance |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical company | Commercial Services |
